Market Cap 2.81B
Revenue (ttm) 434.43M
Net Income (ttm) 275.19M
EPS (ttm) N/A
PE Ratio 11.02
Forward PE N/A
Profit Margin 63.35%
Debt to Equity Ratio 0.00
Volume 1,416,200
Avg Vol 1,332,800
Day's Range N/A - N/A
Shares Out 61.38M
Stochastic %K 74%
Beta 2.30
Analysts Strong Sell
Price Target $67.80

Latest News on PTGX

Protagonist Therapeutics Reports Granting of Inducement Award

Apr 16, 2025, 4:05 PM EDT - 7 days ago

Protagonist Therapeutics Reports Granting of Inducement Award


Overlooked Stock: PTGX

Mar 10, 2025, 4:57 PM EDT - 6 weeks ago

Overlooked Stock: PTGX


Why Is Protagonist Therapeutics Stock Trading Higher On Monday?

Mar 10, 2025, 10:04 AM EDT - 6 weeks ago

Why Is Protagonist Therapeutics Stock Trading Higher On Monday?


Protagonist Therapeutics Reports Granting of Inducement Awards

Jan 6, 2025, 4:05 PM EST - 3 months ago

Protagonist Therapeutics Reports Granting of Inducement Awards


Protagonist Receives $34 Million from Warrant Exercises

Aug 9, 2023, 7:00 AM EDT - 1 year ago

Protagonist Receives $34 Million from Warrant Exercises